Inflammatory cytokines such as IL−6, CRP and sCD40L have been shown to reflect the progression of colorectal cancer and predict tumor relapse, but most of them are postulated as indirect surrogate prognosis factors due to their correlation with already established WHO pathological grading criteria [69]. Here, CRP is linked to neoplasm.